Full Text View
Tabular View
No Study Results Posted
Related Studies
A Bioequivalence Study of Tobramycin and Prednisolone Acetate Compared to PredForte
This study has been completed.
Study NCT00198523   Information provided by ISTA Pharmaceuticals
First Received: September 13, 2005   Last Updated: January 15, 2007   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Eye Infections
Postoperative Complications
Additional conditions recognized in this trial
Infection
More general conditions related to this trial
Eye Diseases
Pathologic Processes
Additional drug interventions recognized in this trial
Methylprednisolone
Methylprednisolone acetate
Methylprednisolone Hemisuccinate
Prednisolone
Prednisolone acetate
Tobramycin
More general drug interventions related to this trial
Anti-Bacterial Agents
Anti-Infective Agents
Anti-Inflammatory Agents
Antiemetics
Antineoplastic Agents
Antineoplastic Agents, Hormonal
Autonomic Agents
Central Nervous System Agents
Gastrointestinal Agents
Glucocorticoids
Hormones
Hormones, Hormone Substitutes, and Hormone Antagonists
Neuroprotective Agents
Peripheral Nervous System Agents
Pharmacologic Actions
Physiological Effects of Drugs
Protective Agents
Therapeutic Uses
Sponsors listed in this trial
ISTA Pharmaceuticals


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services